Since the European Commission published their proposal for the new regulation in September 2014, there have been various publications and announcements which indicate how the various stakeholders have taken to the proposals. Most recently, the European Parliament published their draft report on the Commission’s proposal, which introduced a number of interesting amendments. Will Drury, Senior Business Associate at Cyton Biosciences Ltd reviews the amendments proposed by the European Parliament and endeavours to put them into the context of how the various stakeholders have reacted so far.